Approval · Notice of Compliance 12485 · 2011
REOPRO: Notice of Compliance 12485
Issued June 27, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12485
- Date
- June 27, 2011
- Company
- Centocor Ortho Biotech Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Monoclonal antiplatelet antibody
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REOPRO | 02216973 | Cancelled Post Market |
Medicinal ingredients
- ABCIXIMAB 2 MG per ML